Cancer control programs often don't address radon concerns

August 15, 2013
Cancer control programs often don't address radon concerns
Fewer than half of the National Comprehensive Cancer Control Program plans address radon-related activities, according to a study published in the Aug. 8 issue of the U.S. Centers for Disease Control and Prevention's Preventing Chronic Disease.

(HealthDay)—Fewer than half of the National Comprehensive Cancer Control Program plans address radon-related activities, according to a study published in the Aug. 8 issue of the U.S. Centers for Disease Control and Prevention's Preventing Chronic Disease.

Antonio Neri, M.D., from the CDC in Atlanta, and colleagues reviewed 65 cancer plans created from 2005 to 2011 and categorized their radon-related activities as radon awareness, home testing, remediation, supporting radon policy activities, or policy evaluation. Alignment with existing radon-specific policies in each state was assessed.

The researchers found that 42 percent of the plans reviewed had radon-specific terminology. All 27 of these plans included improving radon awareness; home testing was included in 21; remediation in 11; support for radon policy activities in 13; and one included policy evaluation. Current engagement in radon activities was noted in three plans. Radon-specific laws were present in 30 states with most (21) related to radon professional licensure. Cancer plan activities were aligned with existing state radon laws in 11 states.

"Although several states have radon-specific policies, approximately half of cancer coalitions may not be aware of radon as a public health issue," the authors write. "Comprehensive Cancer Control-developed cancer coalitions and plans should prioritize to address but should consider addressing radon through partnership with existing radon control programs."

Explore further: Suggested link between radon and skin cancer

More information: Full Text

Related Stories

Recommended for you

Discovery of genetic mutation may boost cancer therapies

February 24, 2017

A newly discovered type of genetic mutation that occurs frequently in cancer cells may provide clues about the disease's origins and offer new therapeutic targets, according to research from Weill Cornell Medicine and the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.